FDA Considering '3-Parent Babies' New Day – CNN.com Blogs

A promising way to stop a deadly disease, or an uncomfortable step toward what one leading ethicist called eugenics?

U.S. health officials are weighing whether to approve trials of a pioneering in vitro fertilization technique using DNA from three people in an attempt to prevent illnesses like muscular dystrophy and respiratory problems. The proposed treatment would allow a woman to have a baby without passing on diseases of the mitochondria, the "powerhouses" that drive cells.

The procedure is "not without its risks, but it's treating a disease," medical ethicist Art Caplan told CNN's "New Day" on Wednesday. Preventing a disease that can be passed down for generations would be ethical "as long as it proves to be safe," he said.

"These little embryos, these are people born with a disease, they can't make power. You're giving them a new battery. That's a therapy. I think that's a humane ethical thing to do," said Caplan, the director of medical ethics at New York University's Langone Medical Center.

"Where we get into the sticky part is, what if you get past transplanting batteries and start to say, 'While we're at it, why don't we make you taller, stronger, faster or smarter?' "

But Susan Solomon, the director of the New York Stem Cell Foundation, said there are no changes to existing genes involved.

"There is no genetic engineering. It isn't a slippery slope. It's a way to allow these families to have healthy children," said Solomon, whose organization developed the technique along with Columbia University researchers.

"What we're doing is, without at all changing the DNA of the mother, just allowing it to grow in an environment that isn't sick," she added.

A Food and Drug Administration advisory panel concluded two days of hearings into the procedure Wednesday. The panel discussed what controls might be used in trials, how a developing embryo might be monitored during those tests and who should oversee the trials, but no decisions were made at the end of the session.

Mitochondrial disorders are inherited from the mother. In the procedure under discussion in Washington, genetic material from the nucleus of a mother's egg or an embryo gets transferred to a donor egg or embryo that's had its nuclear DNA removed.

Here is the original post:
FDA Considering '3-Parent Babies' New Day - CNN.com Blogs